News

Cognivue is as Effective as MoCA While Demonstrating Better Test-Retest Reliability for Assessing Cognitive Impairment, According to New Paper

Study Published in Neurological Sciences and Neurosurgery Shows FDA-Cleared Technology as Having Superior Test-Retest Reliability; Affirms Use as Efficient, Easy-to-Use Alternative to Traditional Pencil-and-Paper Assessment Methods ROCHESTER, N.Y., June 25, 2021—Neuroscience company…

Cognivue, Inc. and the American Institute of Balance Announce Inaugural Thought Leader Summit

Cognivue, Inc. and the American Institute of Balance Announce Inaugural Thought Leader Summit June 25-26, 2021 Audiology and otolaryngology leaders will discuss the industry’s role as part of a standard of care…

Cognivue, Inc. Joins Milken Institute’s Alliance to Improve Dementia Care Steering Committee

Cognivue, Inc. Joins Milken Institute’s Alliance to Improve Dementia Care Steering Committee The Alliance seeks to transform and improve the complex health and long-term care systems for individuals at risk for and…

Cognivue to Participate in Major Clinical Study with Global Alzheimer’s Platform

First FDA-cleared computerized test of cognitive function will be evaluated in the Bio-Hermes study; seeks to improve identification and screening…

Cognivue CMO Newsletter, Fall 2020

Dr. Fred Ma addresses the COVID-19 pandemic and the role of cognitive testing. Cognivue CMO Newsletter, Fall 2020

Cognivue Appoints Dr. Fred Ma as Chief Medical Officer & Senior Vice President

Cognivue, Inc. has named Fred Ma, MD, PhD, as it’s Chief Medical Officer and Senior Vice President, effective immediately. His nearly four-decade career spans global medical device and pharmaceutical development and commercialization,…

Cognivue’s FDA Clearance Data Published in the World Journal of Psychiatry

We are excited to announce that Cognivue’s peer-reviewed article, “Validity, reliability and psychometric properties of a computerized cognitive assessment” was published in the World Journal of Psychiatry (WJP). Cognivue is an important…

Cognivue Appoints Key Executive Leaders as They Position Themselves for Rapid Growth and Expansion

Cognivue announces the appointment of two key leaders. Joining the company are Dr. Reina Benabou, MD, PhD, as Senior Vice President and Chief Medical Officer and Whitney Parachek as Vice President of…

Dent Neurologic Institute Hosts Free Alzheimer’s Screening Event on November 10 from 9a-2p

Please call 716-250-2000 and make your mandatory reservation today! Dent is the largest outpatient Neurologic Institute in the Country. Cognivue is proud to be a featured sponsor of this event. Commercial

Cognivue is as Effective as MoCA While Demonstrating Better Test-Retest Reliability for Assessing Cognitive Impairment, According to New Paper

Study Published in Neurological Sciences and Neurosurgery Shows FDA-Cleared Technology as Having Superior Test-Retest Reliability; Affirms Use as Efficient, Easy-to-Use Alternative to Traditional Pencil-and-Paper Assessment Methods ROCHESTER, N.Y., June 25, 2021—Neuroscience company…

Cognivue, Inc. and the American Institute of Balance Announce Inaugural Thought Leader Summit

Cognivue, Inc. and the American Institute of Balance Announce Inaugural Thought Leader Summit June 25-26, 2021 Audiology and otolaryngology leaders will discuss the industry’s role as part of a standard of care…

Cognivue, Inc. Joins Milken Institute’s Alliance to Improve Dementia Care Steering Committee

Cognivue, Inc. Joins Milken Institute’s Alliance to Improve Dementia Care Steering Committee The Alliance seeks to transform and improve the complex health and long-term care systems for individuals at risk for and…

Cognivue to Participate in Major Clinical Study with Global Alzheimer’s Platform

First FDA-cleared computerized test of cognitive function will be evaluated in the Bio-Hermes study; seeks to improve identification and screening…

Cognivue CMO Newsletter, Fall 2020

Dr. Fred Ma addresses the COVID-19 pandemic and the role of cognitive testing. Cognivue CMO Newsletter, Fall 2020

Cognivue Appoints Dr. Fred Ma as Chief Medical Officer & Senior Vice President

Cognivue, Inc. has named Fred Ma, MD, PhD, as it’s Chief Medical Officer and Senior Vice President, effective immediately. His nearly four-decade career spans global medical device and pharmaceutical development and commercialization,…

Cognivue’s FDA Clearance Data Published in the World Journal of Psychiatry

We are excited to announce that Cognivue’s peer-reviewed article, “Validity, reliability and psychometric properties of a computerized cognitive assessment” was published in the World Journal of Psychiatry (WJP). Cognivue is an important…

Cognivue Appoints Key Executive Leaders as They Position Themselves for Rapid Growth and Expansion

Cognivue announces the appointment of two key leaders. Joining the company are Dr. Reina Benabou, MD, PhD, as Senior Vice President and Chief Medical Officer and Whitney Parachek as Vice President of…

Dent Neurologic Institute Hosts Free Alzheimer’s Screening Event on November 10 from 9a-2p

Please call 716-250-2000 and make your mandatory reservation today! Dent is the largest outpatient Neurologic Institute in the Country. Cognivue is proud to be a featured sponsor of this event. Commercial